cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Caribou Biosciences
12 own
9 watching
Current Price
$3.85
$-0.06
(-1.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
292.96M
52-Week High
52-Week High
8.59000
52-Week Low
52-Week Low
3.44000
Average Volume
Average Volume
1.68M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization292.96M
icon52-Week High8.59000
icon52-Week Low3.44000
iconAverage Volume1.68M
iconDividend Yield--
iconP/E Ratio--
What does the Caribou Biosciences do?
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.
Read More
How much money does Caribou Biosciences make?
News & Events about Caribou Biosciences.
Ticker Report
10 months ago
Caribou Biosciences (NASDAQ:CRBU Get Rating) and Vir Biotechnology (NASDAQ:VIR Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings...
Business Wire
10 months ago
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Caribou Biosciences, Inc. (NASDAQ: CRBU) on behalf of long-term stockholders following a class action complaint that was filed against Caribou on April 11, 2023 with a...
Globe Newswire
11 months ago
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ: CRBU) Johnson Fistel, LLP is investigating potential claims on behalf of Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU) against certain of its officers and directors. If you are a current, long-term...
Globe Newswire
1 year ago
-- CB-012 genome-edited armoring strategy significantly reduced tumor burden and improved overall survival in AML xenograft models -- -- CB-012 IND-enabling studies ongoing; IND submission in r/r AML planned for H2 2023 -- BERKELEY, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc...
Globe Newswire
1 year ago
NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou investors who were adversely...
Frequently Asked Questions
Frequently Asked Questions
What is Caribou Biosciences share price today?
plus_minus_icon
Can Indians buy Caribou Biosciences shares?
plus_minus_icon
How can I buy Caribou Biosciences shares from India?
plus_minus_icon
Can Fractional shares of Caribou Biosciences be purchased?
plus_minus_icon
What are the documents required to start investing in Caribou Biosciences stocks?
plus_minus_icon
What is today’s traded volume of Caribou Biosciences?
plus_minus_icon
What is today’s market capitalisation of Caribou Biosciences?
plus_minus_icon
What is the 52-Week High and Low Range of Caribou Biosciences?
plus_minus_icon
What percentage is Caribou Biosciences down from its 52-Week High?
plus_minus_icon
What percentage is Caribou Biosciences up from its 52-Week Low?
plus_minus_icon
Current Price
$3.85
$-0.06
(-1.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00